- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 211/98 - Nitrogen atom
Patent holdings for IPC class C07D 211/98
Total number of patents in this class: 87
10-year publication summary
|
4
|
4
|
3
|
9
|
4
|
7
|
7
|
7
|
5
|
5
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Alkermes, Inc. | 136 |
5 |
| Ensysce Biosciences, Inc. | 24 |
5 |
| Incyte Corporation | 1066 |
5 |
| Incyte Holdings Corporation | 608 |
4 |
| Mitsui Chemicals Crop & Life Solutions,Inc. | 175 |
4 |
| Takeda Pharmaceutical Company Limited | 2704 |
3 |
| Bristol-myers Squibb Company | 4756 |
2 |
| F. Hoffmann-La Roche AG | 7777 |
2 |
| Janssen Pharmaceutica N.V. | 3125 |
2 |
| ACADIA Pharmaceuticals Inc. | 184 |
2 |
| Cytokinetics, Inc. | 252 |
2 |
| Institut de Recherche pour le Developpement (ird) | 146 |
2 |
| Johnson Matthey Public Limited Company | 1771 |
2 |
| Orion Corporation | 798 |
2 |
| Purdue Pharma L.P. | 431 |
2 |
| Receptos LLC | 57 |
2 |
| Xizang Haisco Pharmaceutical Co., Ltd. | 146 |
2 |
| Hoffmann-La Roche Inc. | 3878 |
1 |
| Samsung Display Co., Ltd. | 39369 |
1 |
| The Regents of the University of California | 20989 |
1 |
| Other owners | 36 |